<p>Sei Investments Co. 在第二季度將其在 Icon Plc (NASDAQ:ICLR - 免費報告) 的持股比例提高了 104.4%，根據該公司最近向證券交易委員會的披露。該公司在此期間購買了額外的 309,635 股後，持有 606,227 股這家醫療研究公司的股票。根據其最近向證券交易委員會的備案，Sei Investments Co. 擁有約 0.75% 的 Icon，價值 88,176,000 美元。</p>
<ul>
<li>3 傢俱有長期順風的醫療保健先鋒</li>
</ul>
<p>其他大型投資者也增加或減少了對該公司的持股。Artisan Partners Limited Partnership 在第二季度將其在 Icon 的持股提高了 67.4%。Artisan Partners Limited Partnership 目前擁有 7,184,870 股這家醫療研究公司的股票，價值 1,045,039,000 美元，此前在上個季度又收購了 2,893,946 股。挪威銀行在第二季度新購入了價值 158,639,000 美元的 Icon 股票。1832 Asset Management L.P. 在第二季度將其在 Icon 的持股增加了 587.9%。1832 Asset Management L.P. 目前擁有 1,151,328 股這家醫療研究公司的股票，價值 167,461,000 美元，此前在此期間又購買了 983,950 股。馬薩諸塞金融服務公司在第二季度將其在 Icon 的持股提高了 21.0%。馬薩諸塞金融服務公司目前擁有 3,752,008 股這家醫療研究公司的股票，價值 545,730,000 美元，此前在上個季度又購買了 650,379 股。最後，Equity Investment Corp 在第二季度新購入了價值約 82,264,000 美元的 Icon 股票。機構投資者和對沖基金持有該公司 95.61% 的股票。</p>
<h2>華爾街分析師觀點</h2>
<p>ICLR 已成為多份分析師報告的主題。Rothschild Redb 在 9 月 3 日的研究報告中將 Icon 的股票評級從 “持有” 上調至 “強烈買入”。Robert W. Baird 在 10 月 24 日的研究報告中對 Icon 的股票設定了 220.00 美元的目標價。Zacks Research 在 11 月 25 日的研究報告中將 Icon 的股票評級從 “強烈賣出” 上調至 “持有”。Weiss Ratings 在 12 月 1 日的報告中重申了對 Icon 股票的 “持有 (c-)” 評級。最後，Rothschild &amp; Co Redburn 在 9 月 3 日的報告中將 Icon 的評級從 “中性” 上調至 “買入”，並將其股票目標價從 184.00 美元提高至 236.00 美元。兩位分析師對該股票給予了強烈買入評級，八位分析師給予了買入評級，十位分析師給予了持有評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，共識目標價為 205.00 美元。</p>
<ul>
<li>你應該把愛爾蘭的好運帶到你的投資中嗎？</li>
</ul>
<p><strong>閲讀我們關於 ICLR 的最新研究報告</strong></p>
<h2>Icon 股票表現</h2>
<p>NASDAQ ICLR 週五開盤價為 189.93 美元。該公司的 50 日移動平均價格為 176.65 美元，200 日移動平均價格為 166.03 美元。該股票的市值為 153.4 億美元，市盈率為 25.70，市盈增長比率為 3.40，貝塔係數為 1.25。該公司的債務與股本比率為 0.31，速動比率為 1.06，流動比率為 1.06。Icon Plc 的 52 周低點為 125.10 美元，52 周高點為 228.29 美元。</p>
<h2>Icon 公司簡介</h2>
<p>(免費報告)</p>
<p>ICON 公共有限公司是一家臨牀研究組織，提供在愛爾蘭、歐洲其他地區、美國及國際上的外包開發和商業化服務。該公司專注於支持臨牀開發過程各個階段的項目的戰略開發、管理和分析，從化合物選擇到 I-IV 期臨牀研究。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票比 Icon 更好</li>
<li>如何選擇頂級評級股票</li>
<li>2026 年應避免的 3 只最近被下調的股票</li>
<li>如何投資藍籌股</li>
<li>芯片熱潮迴歸：3 只有巨大收益潛力的股票</li>
<li>3 只小盤股具有高回報潛力</li>
<li>甲骨文股票遭重創：為何其 AI 管道可能推動 2026 年的反彈</li>
</ul>
<p><strong>想看看其他對沖基金持有什麼 ICLR 嗎？</strong> 訪問 HoldingsChannel.com 獲取 Icon Plc (NASDAQ:ICLR - 免費報告) 的最新 13F 備案和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Icon 嗎？</h2>
<p>在你考慮 Icon 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Icon 並不在名單上。</p>
<p>雖然 Icon 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

ICLR

<p>Sei Investments Co. 在第二季度將其在 Icon Plc 的股份增加了 104.4%，目前持有 606,227 股，價值 8,818 萬美元。其他主要投資者也增加了他們的持股。Icon 的股票共識評級為 “適度買入”，目標價格為 205.00 美元。該股票在週五以 189.93 美元開盤，市值為 153.4 億美元</p>

<p>Sei Investments Co. lifted its stake in Icon Plc (NASDAQ:ICLR - Free Report) by 104.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 606,227 shares of the medical research company's stock after buying an additional 309,635 shares during the period. Sei Investments Co. owned approximately 0.75% of Icon worth $88,176,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>Sei Investments Co. 在第二季度將其在 Icon Plc (NASDAQ:ICLR - 免費報告) 的持股比例提高了 104.4%，根據該公司最近向證券交易委員會的披露。該公司在此期間購買了額外的 309,635 股後，持有 606,227 股這家醫療研究公司的股票。根據其最近向證券交易委員會的備案，Sei Investments Co. 擁有約 0.75% 的 Icon，價值 88,176,000 美元。</p>
</div><ul>
<li>3 Healthcare Pathbreakers With Long-Term Tailwinds</li>
</ul>
<div class="lb-trans"><ul>
<li>3 傢俱有長期順風的醫療保健先鋒</li>
</ul>
</div><p>Other large investors have also added to or reduced their stakes in the company. Artisan Partners Limited Partnership raised its holdings in Icon by 67.4% in the 2nd quarter. Artisan Partners Limited Partnership now owns 7,184,870 shares of the medical research company's stock valued at $1,045,039,000 after acquiring an additional 2,893,946 shares in the last quarter. Norges Bank acquired a new stake in shares of Icon during the 2nd quarter worth $158,639,000. 1832 Asset Management L.P. increased its position in shares of Icon by 587.9% in the second quarter. 1832 Asset Management L.P. now owns 1,151,328 shares of the medical research company's stock worth $167,461,000 after purchasing an additional 983,950 shares during the period. Massachusetts Financial Services Co. MA raised its stake in Icon by 21.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,752,008 shares of the medical research company's stock valued at $545,730,000 after purchasing an additional 650,379 shares in the last quarter. Finally, Equity Investment Corp bought a new stake in Icon during the second quarter worth about $82,264,000. Institutional investors and hedge funds own 95.61% of the company's stock.</p>
<div class="lb-trans"><p>其他大型投資者也增加或減少了對該公司的持股。Artisan Partners Limited Partnership 在第二季度將其在 Icon 的持股提高了 67.4%。Artisan Partners Limited Partnership 目前擁有 7,184,870 股這家醫療研究公司的股票，價值 1,045,039,000 美元，此前在上個季度又收購了 2,893,946 股。挪威銀行在第二季度新購入了價值 158,639,000 美元的 Icon 股票。1832 Asset Management L.P. 在第二季度將其在 Icon 的持股增加了 587.9%。1832 Asset Management L.P. 目前擁有 1,151,328 股這家醫療研究公司的股票，價值 167,461,000 美元，此前在此期間又購買了 983,950 股。馬薩諸塞金融服務公司在第二季度將其在 Icon 的持股提高了 21.0%。馬薩諸塞金融服務公司目前擁有 3,752,008 股這家醫療研究公司的股票，價值 545,730,000 美元，此前在上個季度又購買了 650,379 股。最後，Equity Investment Corp 在第二季度新購入了價值約 82,264,000 美元的 Icon 股票。機構投資者和對沖基金持有該公司 95.61% 的股票。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>ICLR has been the subject of several analyst reports. Rothschild Redb upgraded shares of Icon from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Wednesday, September 3rd. Robert W. Baird set a $220.00 price objective on shares of Icon in a research note on Friday, October 24th. Zacks Research upgraded shares of Icon from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, November 25th. Weiss Ratings reaffirmed a &#34;hold (c-)&#34; rating on shares of Icon in a report on Monday, December 1st. Finally, Rothschild &amp; Co Redburn raised Icon from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and boosted their price target for the stock from $184.00 to $236.00 in a report on Wednesday, September 3rd. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and ten have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $205.00.</p>
<div class="lb-trans"><p>ICLR 已成為多份分析師報告的主題。Rothschild Redb 在 9 月 3 日的研究報告中將 Icon 的股票評級從 “持有” 上調至 “強烈買入”。Robert W. Baird 在 10 月 24 日的研究報告中對 Icon 的股票設定了 220.00 美元的目標價。Zacks Research 在 11 月 25 日的研究報告中將 Icon 的股票評級從 “強烈賣出” 上調至 “持有”。Weiss Ratings 在 12 月 1 日的報告中重申了對 Icon 股票的 “持有 (c-)” 評級。最後，Rothschild &amp; Co Redburn 在 9 月 3 日的報告中將 Icon 的評級從 “中性” 上調至 “買入”，並將其股票目標價從 184.00 美元提高至 236.00 美元。兩位分析師對該股票給予了強烈買入評級，八位分析師給予了買入評級，十位分析師給予了持有評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，共識目標價為 205.00 美元。</p>
</div><ul>
<li>Should You Bring The Luck Of The Irish To Your Investmets?</li>
</ul>
<div class="lb-trans"><ul>
<li>你應該把愛爾蘭的好運帶到你的投資中嗎？</li>
</ul>
</div><p><strong>Read Our Latest Research Report on ICLR</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 ICLR 的最新研究報告</strong></p>
</div><h2>Icon Stock Performance</h2>
<div class="lb-trans"><h2>Icon 股票表現</h2>
</div><p>NASDAQ ICLR opened at $189.93 on Friday. The firm's fifty day moving average price is $176.65 and its two-hundred day moving average price is $166.03. The stock has a market cap of $15.34 billion, a PE ratio of 25.70, a PEG ratio of 3.40 and a beta of 1.25. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 1.06. Icon Plc has a fifty-two week low of $125.10 and a fifty-two week high of $228.29.</p>
<div class="lb-trans"><p>NASDAQ ICLR 週五開盤價為 189.93 美元。該公司的 50 日移動平均價格為 176.65 美元，200 日移動平均價格為 166.03 美元。該股票的市值為 153.4 億美元，市盈率為 25.70，市盈增長比率為 3.40，貝塔係數為 1.25。該公司的債務與股本比率為 0.31，速動比率為 1.06，流動比率為 1.06。Icon Plc 的 52 周低點為 125.10 美元，52 周高點為 228.29 美元。</p>
</div><h2>Icon Profile</h2>
<div class="lb-trans"><h2>Icon 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.</p>
<div class="lb-trans"><p>ICON 公共有限公司是一家臨牀研究組織，提供在愛爾蘭、歐洲其他地區、美國及國際上的外包開發和商業化服務。該公司專注於支持臨牀開發過程各個階段的項目的戰略開發、管理和分析，從化合物選擇到 I-IV 期臨牀研究。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Icon</li>
<li>How to Choose Top Rated Stocks</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
<li>3 Small Caps With Big Return Potential</li>
<li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票比 Icon 更好</li>
<li>如何選擇頂級評級股票</li>
<li>2026 年應避免的 3 只最近被下調的股票</li>
<li>如何投資藍籌股</li>
<li>芯片熱潮迴歸：3 只有巨大收益潛力的股票</li>
<li>3 只小盤股具有高回報潛力</li>
<li>甲骨文股票遭重創：為何其 AI 管道可能推動 2026 年的反彈</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ICLR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有什麼 ICLR 嗎？</strong> 訪問 HoldingsChannel.com 獲取 Icon Plc (NASDAQ:ICLR - 免費報告) 的最新 13F 備案和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ICLR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Icon Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Icon 嗎？</h2>
</div><p>Before you consider Icon, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Icon 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Icon wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Icon 並不在名單上。</p>
</div><p>While Icon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Icon 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Sei Investments Co. 收購了 Icon Plc 的 309,635 股股份，股票代碼為 $ICLR